Picture of Damora Therapeutics logo

DMRA — Damora Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Galecto Inc reports results for the quarter ended in June - Earnings Summary

* Galecto Inc  GLTO.OQ  reported a quarterly adjusted loss of 49
cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 54 cents per
share.
* Reported revenue was zero​;  analysts expected zero. 
* Galecto Inc's reported EPS for the quarter was a loss of 49
cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Galecto Inc shares had fallen by 14.0% this quarter and
lost 65.2% so far this year.
* The company reported a quarterly loss of $12.3 million.
* Wall Street's median 12-month price target for Galecto Inc is
$14.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 06:31 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Damora Therapeutics

See all news